Salarius Pharmaceuticals, Inc.
SLRX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$873 | -$958 | -$1,710 | -$1,464 |
| Dep. & Amort. | $1 | $1 | $1 | $1 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $23 | $23 | $34 | $51 |
| Change in WC | -$797 | $71 | $493 | $669 |
| Other Non-Cash | $0 | $0 | $0 | $0 |
| Operating Cash Flow | -$1,647 | -$862 | -$1,182 | -$743 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | -$200 | $0 | $0 | $0 |
| Investing Cash Flow | -$200 | $0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | -$112 | -$110 | -$107 |
| Stock Issued | $0 | -$29 | $655 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $5,861 | $0 | $0 | $0 |
| Financing Cash Flow | $5,861 | -$141 | $546 | -$107 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $4,015 | -$1,003 | -$636 | -$850 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $795 | $1,798 | $2,435 | $3,284 |
| End Cash | $4,810 | $795 | $1,798 | $2,435 |
| Free Cash Flow | -$1,647 | -$862 | -$1,182 | -$743 |